This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Afobazol

Russian non-benzodiazepine anxiolytic.

Aliases (3)

Afobazole · fabomotizole · CM-346

TYPICAL DOSE

—

ROUTE

—

CYCLE

—

STORAGE

—

Overview

What is Afobazol?

Russian non-benzodiazepine anxiolytic. Sigma-1 + melatonin receptor + NGF mechanism. Claims anxiolysis without sedation or dependence. Russian RCT base only; no Western replication. WATCH-LIST.

What to Expect

Week 1
Tolerability and dose-response.
Week 2-4
Early effect window.
Week 4-8
Peak benefit assessment.
Week 8+
Cycle decision point.

Was this helpful?

Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

✎

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load ▸

Loading…

Continue: Extended research →

Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Afobazol

Russian/Soviet-developed pyridoxine-derived antioxidant + GABAergic + neurotransmitter modulator. Approved in Russia for cerebrovascular insufficiency, anxiety, alcohol withdrawal, asthenia. NOT FDA-approved in US. Research-chem / Russian-pharma import only. Not WADA-banned.

STRONG-CANDIDATE

Russian-peptide (synthetic ACTH(4-10) heptapeptide analog, neurotrophic / nootropic)

STRONG-CANDIDATE

Russian-peptide (synthetic tuftsin analog, anxiolytic + immunomodulator + nootropic heptapeptide)

STRONG-CANDIDATE

Adaptogen — withanolide-rich Solanaceae root extract; HPA-axis modulator

STRONG-CANDIDATE

Non-proteinogenic amino acid; glutamate / glutamine analog

Azapirone — partial 5-HT1A receptor agonist; non-benzodiazepine anxiolytic